SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

X4 Pharmaceuticals Q3 Results Due October 29; EPS Estimate Is a Loss

X4 Pharmaceuticals is expected to report Q3'26 results on October 29. Estimates call for a loss per share and revenue; the release time is not specified.

XFOR

XFOR (X4 Pharmaceuticals, Inc.) is set to announce its Q3'26 results on October 29, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 2.30 million USD with EPS (earnings per share) anticipated at (0.18) USD. Learn more details…